Response to the letter entitled: Re: 'Prognostic value of high-risk HPV DNA and p16INK4a immunohistochemistry in anal cancer patients: An individual patient data meta-analysis'

Eur J Cancer. 2022 Aug:171:282-283. doi: 10.1016/j.ejca.2022.04.031. Epub 2022 Jun 23.
No abstract available

Publication types

  • Letter
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anus Neoplasms*
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA
  • Humans
  • Immunohistochemistry
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / complications
  • Prognosis

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA